Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Significance: Ketamine is an NMDA receptor (NMDAR) antagonist that elicits rapid antidepressant responses in patients with treatment-resistant depression. However, ketamine can also produce adverse side effects, which raised interest in whether the clinically tolerated NMDAR antagonist memantine can elicit similar fast antidepressant action. Rather surprisingly, clinical data have shown that memantine does not trigger rapid antidepressant effects for reasons that have yet to be elucidated. Here, we reconstitute the ketamine and memantine clinical findings in animal models and, combined with the analysis of synaptic function and subsequent intracellular signaling, demonstrate significant differences between the efficacies of ketamine and memantine on NMDAR-mediated neurotransmission and downstream intracellular signaling. These findings suggest a potential mechanism to explain the earlier clinical observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This differential effect of ketamine and memantine extended to intracellular signaling coupled to spontaneous NMDA receptors, in that memantine does not inhibit eEF2K nor alter BDNF protein expression in the hippocampus, key determinants of ketamine mediated rapid antidepressant effects (Gideons et al., 2014).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Gideons et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“Work done in our laboratory demonstrated that memantine has little effect on the function of NMDA receptors activated by spontaneous neurotransmitter release, in contrast to ketamine.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Gideons et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, memantine, a non-competitive NMDAR channel blocker, failed to exert antidepressant actions in animal tests 64 and in humans 65–67, and which was suggested to be because memantine does not block NMDAR-mEPSCs under physiological Mg2+ levels 64.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ketamine’s inhibition of NMDAR-mEPSCs occurs at physiological levels of Mg2+, an effect that was associated with the rapid antidepressant behavioral actions of ketamine 64.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“The rapid antidepressant effects of ketamine have also been suggested to be mediated by mammalian target of rapamycin (mTOR)-dependent synapse formation, although it remains unclear how blockade of the NMDAR activates mTOR (30).”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 10×
“In recent work, we demonstrated that the fast-acting antidepressant effect of ketamine requires deactivation of eukaryotic elongation factor 2 kinase (eEF2K) and subsequent desuppression of BDNF protein translation in the hippocampus (8, 9).”
BackgroundMethodResultSelf-citationMaeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · cited 1×
“In all experiments, we included a ketamine group as a direct comparison, which has previously been shown to elicit an antidepressant response in mice 30 min after administration without effects on locomotor activity at this time point (8, 9, 14, 15).”
MethodParsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878 · cited 2×
“Pharmacol Biochem Behav 53(4): 791–797.”
BackgroundExcitatory glycine receptors containing the NR3 family of NMDA receptor subunits
Chatterton, J. E., Awobuluyi, M., Premkumar, L. S., Takahashi, H., Talantova, M., Shin, Y., Cui, J., Tu, S., Sevarino, K. A., Nakanishi, N., et al. (2002) · Nature · doi:10.1038/nature715 · Cited by 694 · cited 1×
“Additionally, it seems unlikely that any differences found between ketamine and memantine would be mediated by GluN3 containing NMDARs, because they do not show significant sensitivity to blockade by Mg or use dependent blockers (23, 24).”
BackgroundSutton, M. A., Ito, H. T., Cressy, P., Kempf, C., Woo, J. C., & Schuman, E. M. (2006) · Cell · doi:10.1016/j.cell.2006.03.040 · Cited by 633 · cited 1×
“Blockade of NMDAR-mEPSCs has been linked to the control of dendritic protein translation by decreasing calcium influx through the NMDAR into the synapse, leading to decreased phosphorylation of eEF2 by eEF2K and desuppression of protein translation (10, 12), thus providing a potential mechanism for A”
BackgroundPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
Voltage dependence of NMDA-activated macroscopic conductances predicted by single-channel kinetics
Jahr, C., & Stevens, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-03178.1990 · Cited by 564
Cited by
Items 201–230 of 230
Mesripour, A., Purhasani, A., & Hajhashemi, V. (2019) · The Thai Journal of Pharmaceutical Sciences · doi:10.56808/3027-7922.2356 · Cited by 4
Kétamine et suicidalité : modèles animaux pour comprendre son mécanisme d’action
Nguyen, T. M. L., Jollant, F., Tritschler, L., Colle, R., Corruble, E., & Gardier, A. M. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2023.10.008 · Cited by 2
Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies
Hermes, G., & Sanacora, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0_6 · Cited by 1
Research progress in the mechanisms of the clinical effects of ketamine
Shuai, C. A. O., & Wang, Y. (2016) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972016-00846 · Cited by 1
Neurophysiologic Advance in Depressive Disorder
Xu, L., & Mao, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_5 · Cited by 1
Activation of the TrkB Neurotrophin Receptor by Antidepressant Drugs
Antila, H. (2016) · Helda - University of Helsinki Institutional Repository · Cited by 1
Potential of Polyphenols in the Treatment of Major Depression
Dhir, A. (2017) · Wiley eBooks · doi:10.1002/9781119155195.ch12 · Cited by 3
Impact of open channel blockers on the surface dynamics and organization of NMDA receptors
Fernandes, A. (2020) · theses.fr (ABES) · doi:10.70675/d12c14b2z7a80z4668z9c48z8e2c0e41c009 · Cited by 2
Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events
Emnett, C. M. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7wm1bj6
“For instance, a recent study shows that ketamine, but not memantine, can block spontaneous events (mEPSCs) in the presence of physiological magnesium (Gideons et al., 2014).”
BackgroundInfluentialEmerging Data for Ketamine in Obsessive-Compulsive, Stress-Related, and Substance Use Disorders
Rodríguez, C. I., & Dakwar, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0_9
Mechanisms of NMDA receptor inhibition by memantine and ketamine
Glasgow, N. G. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Calcium regulation of inhibitory synaptic transmission
Willliams, C. (2016)
Ketamine-Based Treatment of MDD: A Biologist’s Perspective
Li, S., Zhang, Y., & Zhou, Q. (2017) · Journal of Depression And Therapy · doi:10.14302/issn.2476-1710.jdt-17-1673
Stovezky, Y. R., Gershkovich, M., Kayser, R. R., & Simpson, H. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.020
The Search for Rapid Acting Antidepressants: Research Synthesis and Perspectives
Sanacora, G., Kitay, B. M., & Wilkinson, S. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00035-4
Bączyńska, E., Krzystyniak, A., Zaręba-Kozioł, M., Figiel, I., Włodarczyk, J., & Wójtowicz, T. (2020) · Kosmos · doi:10.36921/kos.2020_2637 · Cited by 1
Ketamine: an «atypical» antidepressant, a new effect of the old analgesic
Churyukanov, V. V., & Churyukanov, M. V. (2021) · Russian Journal of Pain · doi:10.17116/pain20211901140
Doan, J. (2020) · theses.fr (ABES) · doi:10.70675/4cac5eccz728az41a4z8461z85b9e8ddfa1e · Cited by 1
Möhler, H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732838229.793560282
Duman, R. S. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726084835.793546102
Truncated Tyrosine Kinase Receptor B (TrkB.T1) plays a role in susceptibility to chronic stress
Khalaf, S. (2020) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2020-14183
Duman, R. S. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732838229.793546101
Ketamine - mechanisms of action as an antidepressant
Gębik, B., Bliźniewska-Kowalska, K. M., & Gałecki, P. (2026) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/202128
“It is suggested, that under the physiological concentration of Mg 2+ inside ion canal, memantine does not inhibit NMDA receptor subunits involved in spontaneous glutamate release, whereas ketamine does [58].”
Ketamine’s Multifaceted Neuropharmacological and Neurobiological Actions
Kohtala, S., & Annala, I. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_2
Atasoy-Rodriguez, I. L., Johnson, K. W., Patel, K., Arain, H., Zaidi, S., Herold, K. F., Milner, T. A., Hemmings, H. C., & Platholi, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.02.697407 · Cited by 1
“At resting membrane potentials, the NMDAR pore is largely blocked by extracellular magnesium (Mg 2+ ) 91 ; however, this block is incomplete under physiological conditions, permitting small residual currents 92, 93 that can be inhibited by ketamine or MK-801 94 95 through mechanisms involving transient Mg 2+ block 69,…”
InfluentialNMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry
Freyssin, A., Benabou, R., Müller, H. Z., Davis, S., Perin-Dureau, F., Danker, T., & Rubinstenn, G. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111742
Modulating glutamate neurotransmission in in vivo models of Multiple Sclerosis: a narrative review
Stamoula, E., Vavilis, T., Boskou, I., Vampertzi, O., Floropoulou, N., Demopoulos, A., Grigoriou, R., & Melnikov, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1811323
“Ketamine in contrast to memantine inhibits the phosphorylation of eukaryotic elongation factor 2 and augments expression of BDNF (106).”
Hemiplegic migraine: genetics and pathophysiology
Pietrobon, D. (2026) · Journal of Clinical Investigation · doi:10.1172/jci208001
Metadata
- Authors
- Gideons, E. S., Kavalali, E. T., & Monteggia, L. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-05-27
- Volume
- 111
- Issue
- 23
- Pages
- 8649-8654
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4060670
- OpenAlex
- W2033919519
- Cited by
- 232
- References
- 31
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 15 · 2023: 13 · 2022: 14 · 2021: 16 · 2020: 24 · 2019: 20 · 2018: 23 · 2017: 21 · 2016: 29 · 2015: 24 · 2014: 11
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 070727, R01MH066198, MH-066198, R01MH070727)
- National Institute of Neurological Disorders and Stroke (T32NS069562)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- ketamine, memantine, rapid antidepressant response, treatment-resistant depression, NMDA receptor antagonism, miniature excitatory postsynaptic currents, hippocampal neurons, BDNF expression, intracellular signaling, antidepressant mechanism
- MeSH terms
- Animals, Animals, Newborn, Antidepressive Agents, Cells, Cultured, Hippocampus, Humans, Ketamine, Magnesium, Male, Memantine, Mice, Inbred C57BL, Motor Activity, Neurons, Phosphorylation, Time Factors, Blotting, Western, Receptors, N-Methyl-D-Aspartate, Patch-Clamp Techniques, Excitatory Amino Acid Antagonists, Brain-Derived Neurotrophic Factor, Excitatory Postsynaptic Potentials, Peptide Elongation Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.